Adel Sadeq
-
- Antibiotic Use and Resistance 3
- Sensory Systems top 10%
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 5
- Cognitive Neuroscience top 10%
-
- Heart Failure Treatment and Management 4
- Atrial Fibrillation Management and Outcomes 2
-
- COVID-19 Clinical Research Studies 3
-
- Lipoproteins and Cardiovascular Health 3
-
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Diabetes Treatment and Management 3
Adel Sadeq
25 papers receiving 469 citations
Peers
Comparison fields: 5 of 87
- Applied Microbiology and Biotechnology 17
- Sensory Systems 39
- Geriatrics and Gerontology 31
- Cognitive Neuroscience 136
- Biological Psychiatry 17
Countries citing papers authored by Adel Sadeq
This map shows the geographic impact of Adel Sadeq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Sadeq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Sadeq more than expected).
Fields of papers citing papers by Adel Sadeq
This network shows the impact of papers produced by Adel Sadeq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Sadeq. The network helps show where Adel Sadeq may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adel Sadeq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 9 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 15 | |
| 15 | 2020 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2020 | 63 | |
| 18 | 2018 | 3 | |
| 19 | 2018 | 155 | |
| 20 | 2016 | 126 |
About Adel Sadeq
Adel Sadeq is a scholar working on Applied Microbiology and Biotechnology, Family Practice, Geriatrics and Gerontology, General Dentistry and Cardiology and Cardiovascular Medicine, having authored 26 papers that have together received 477 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (5 papers), Heart Failure Treatment and Management (4 papers), Antibiotic Use and Resistance (3 papers), COVID-19 Clinical Research Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Diabetes Treatment and Management (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (17 citations), Sensory Systems (39 citations), Geriatrics and Gerontology (31 citations), Cognitive Neuroscience (136 citations) and Biological Psychiatry (17 citations). Adel Sadeq has collaborated with scholars based in United Arab Emirates, Saudi Arabia and Egypt. Frequent co-authors include Bassem Sadek, Astrid Sasse, Nermin Eissa, Shreesh Ojha, Holger Stark, Mohammed Al‐Houqani, Ali Saad, Fakhreya Y. Jalal, Asim Ahmed Elnour and Abdu Adem. Their work appears in journals such as Pharmacy Practice, Saudi Pharmaceutical Journal, Current Diabetes Reviews, Behavioural Brain Research and Expert Review of Anti-infective Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.